QoL, CIs, QALYs, and Individualized Rehabilitation: The Clinical and Practical Benefits of Regularly Assessing the Quality of Life of Adult Cochlear Implant Recipients

Author:

Lassaletta Luis12ORCID,Calvino Miryam12ORCID,Sanchez-Cuadrado Isabel1ORCID,Skarzynski Piotr Henryk3ORCID,Cywka Katarzyna B.3ORCID,Czajka Natalia3ORCID,Kutyba Justyna3ORCID,Tavora-Vieira Dayse4ORCID,Van de Heyning Paul5ORCID,Mertens Griet5ORCID,Staecker Hinrich6ORCID,Humphrey Bryan6,Zernotti Mario7ORCID,Zernotti Maximo7ORCID,Magele Astrid8,Ploder Marlene8,Zabeu Julia Speranza9

Affiliation:

1. Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain

2. Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, (CIBERER-U761), 28029 Madrid, Spain

3. Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland

4. Fiona Stanley Fremantle Hospitals Group, Perth 6150, Australia

5. Department of Otorhinolaryngology, Antwerp University Hospital, 2650 Antwerp, Belgium

6. ENT Department, University of Kansas Medical Centre, Kansas City, KS 66160, USA

7. Department of Otorhinolaryngology, Sanatorio Allende de Córdoba, Córdoba 5000, Argentina

8. ENT Department, Universitätsklinikum St. Pölten, 3100 St. Pölten, Austria

9. Hospital de Reabilitacão de Anomalias Craniofaciais da Universidade de Sao Paulo, Campus Bauru, Bauru 17012-230, Brazil

Abstract

This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision.

Funder

MED-EL

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3